149 related articles for article (PubMed ID: 36018836)
1. Congenital myasthenic syndrome: a tale of two siblings.
Banerjee A; Datta Kanjilal S; Biswas T; Ghoshal A; Sarkar S
Int J Neurosci; 2024 Jun; 134(3):253-255. PubMed ID: 36018836
[TBL] [Abstract][Full Text] [Related]
2. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients.
Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S
Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638
[TBL] [Abstract][Full Text] [Related]
3. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
[TBL] [Abstract][Full Text] [Related]
4. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
Tsao CY
Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND.
Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y
Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214
[No Abstract] [Full Text] [Related]
6. Positive response to inhaled salbutamol in congenital myasthenic syndrome due to CHRNE mutation.
Garg D; Goyal V
Muscle Nerve; 2022 Jul; 66(1):E1-E2. PubMed ID: 35466404
[No Abstract] [Full Text] [Related]
7. Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.
Lorenzoni PJ; Scola RH; Kay CS; Filla L; Miranda AP; Pinheiro JM; Chaouch A; Lochmüller H; Werneck LC
J Neurol Sci; 2013 Aug; 331(1-2):155-7. PubMed ID: 23790237
[TBL] [Abstract][Full Text] [Related]
8. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature.
Mishra S; Nair KV; Shukla A
Clin Dysmorphol; 2023 Oct; 32(4):162-167. PubMed ID: 37646703
[TBL] [Abstract][Full Text] [Related]
9. DOK7 congenital myasthenic syndrome responsive to oral salbutamol.
Tayade K; Salunkhe M; Agarwal A; Radhakrishnan DM; Srivastava AK
QJM; 2022 May; 115(5):323-324. PubMed ID: 35092298
[No Abstract] [Full Text] [Related]
10. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
[TBL] [Abstract][Full Text] [Related]
11. COLQ-Related Congenital Myasthenic Syndrome and Response to Salbutamol Therapy.
Padmanabha H; Saini AG; Sankhyan N; Singhi P
J Clin Neuromuscul Dis; 2017 Mar; 18(3):162-163. PubMed ID: 28221310
[No Abstract] [Full Text] [Related]
12. Salbutamol monotherapy in acetylcholine receptor deficiency-related congenital myasthenic syndrome due to CHRNE mutation.
Dutta A; Chakraborty A; Das S; Dubey S; Pandit A
J Neurol; 2022 Jul; 269(7):3923-3925. PubMed ID: 35175423
[No Abstract] [Full Text] [Related]
13. Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol.
Chan SH; Wong VC; Engel AG
Pediatr Neurol; 2012 Aug; 47(2):137-40. PubMed ID: 22759693
[TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenic syndrome: a brief review.
Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
[TBL] [Abstract][Full Text] [Related]
15. Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
Finlayson S; Spillane J; Kullmann DM; Howard R; Webster R; Palace J; Beeson D
Muscle Nerve; 2013 Feb; 47(2):279-82. PubMed ID: 23281026
[TBL] [Abstract][Full Text] [Related]
16. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
[TBL] [Abstract][Full Text] [Related]
17. Limb girdle weakness responding to salbutamol: an Indian family with DOK7 mutation.
Khadilkar S; Bhutada A; Nallamilli B; Hegde M
Indian Pediatr; 2015 Mar; 52(3):243-4. PubMed ID: 25849006
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
[TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndrome due to novel CHAT mutations in an ethnic kadazandusun family.
Tan JS; Ambang T; Ahmad-Annuar A; Rajahram GS; Wong KT; Goh KJ
Muscle Nerve; 2016 May; 53(5):822-6. PubMed ID: 26789281
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.
Ohno K; Ohkawara B; Shen XM; Selcen D; Engel AG
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
